Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T P Miller

Showing results (81-90 of 130) with videos related to

Pageof 13
Sort By:
Investigational New Drugs|January 1, 1994
A Southwest Oncology Group phase II evaluation of fluderabine monophosphate in sarcomaM R Grever, J Benedetti, S P Balcerzak, et al.
Investigational New Drugs|January 1, 1994
Phase II evaluation of mitoxantrone plus cis-platinum in patients with advanced breast cancer. A Southwest Oncology Group studyJ O Atiba, S J Green, H E Hynes, et al.
Seminars in Hematology|April 1, 1987
Southwest oncology group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomasR I Fisher, T P Miller, B W Dana, et al.
Investigational New Drugs|January 19, 2000
Phase II trial of menogaril in non-Hodgkin's lymphomas: a Southwest Oncology Group trialD F Moore, T D Brown, M LeBlanc, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapyB W Dana, S Dahlberg, B N Nathwani, et al.
Leukemia & Lymphoma|July 27, 2016
Prediction of Outcome in Diffuse Large Cell Lymphoma by the Major Histocompatibility Complex Class II (HLA-DR, DP, DQ) and Class I (HLA-A, B, C) PhenotypeJ A Rybski, C M Spier, T P Miller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 11, 1991
Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomasR I Fisher, D L Longo, V T DeVita, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 1, 1990
Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease courseS M Lippman, C M Spier, T P Miller, et al.
Neurobiology of Aging|January 1, 1985
Desglycinamide-9-arginine-8-vasopressin (DGAVP, Organon 5667) in patients with dementiaC A Peabody, S Thiemann, R Pigache, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1991
P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamilT P Miller, T M Grogan, W S Dalton, et al.
Pageof 13

Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
Investigational New Drugs|January 1, 1994
A Southwest Oncology Group phase II evaluation of fluderabine monophosphate in sarcomaM R Grever, J Benedetti, S P Balcerzak, et al.
Investigational New Drugs|January 1, 1994
Phase II evaluation of mitoxantrone plus cis-platinum in patients with advanced breast cancer. A Southwest Oncology Group studyJ O Atiba, S J Green, H E Hynes, et al.
Seminars in Hematology|April 1, 1987
Southwest oncology group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomasR I Fisher, T P Miller, B W Dana, et al.
Investigational New Drugs|January 19, 2000
Phase II trial of menogaril in non-Hodgkin's lymphomas: a Southwest Oncology Group trialD F Moore, T D Brown, M LeBlanc, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapyB W Dana, S Dahlberg, B N Nathwani, et al.
Leukemia & Lymphoma|July 27, 2016
Prediction of Outcome in Diffuse Large Cell Lymphoma by the Major Histocompatibility Complex Class II (HLA-DR, DP, DQ) and Class I (HLA-A, B, C) PhenotypeJ A Rybski, C M Spier, T P Miller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 11, 1991
Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomasR I Fisher, D L Longo, V T DeVita, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 1, 1990
Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease courseS M Lippman, C M Spier, T P Miller, et al.
Neurobiology of Aging|January 1, 1985
Desglycinamide-9-arginine-8-vasopressin (DGAVP, Organon 5667) in patients with dementiaC A Peabody, S Thiemann, R Pigache, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1991
P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamilT P Miller, T M Grogan, W S Dalton, et al.
Pageof 13